Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4.
Yaxing WeiWenjie WuYanan JiangHao ZhouYin YuLili ZhaoXiangyu WuXuebo LuQiang YuanZitong WangZigang DongLuyun HeJimin ZhaoKangdong LiuPublished in: British journal of cancer (2021)
Our findings indicate that Nuplazid can suppress ESCC progression through targeting PAK4.
Keyphrases